Drs. Chang, Krans, and Miller held semistructured interviews with pregnant and postpartum women who have experienced opioid use disorder and intimate partner violence regarding their experiences seeking help with both issues.
Congratulations to Dr. Marian Jarlenski for a successful PCORI grant focused on improving pregnancy-related health outcomes.
Drs. Ashley Hill and Natacha De Genna qualitatively examined coping mechanisms and desired supports in pregnant and birthing Black and biracial adolescent and young adult women during the COVID-19 pandemic. Their team found that nearly half the interviewees reported mental health symptoms consistent with postpartum depression and that several were afraid to disclose their symptoms to a healthcare provider due to fear of child protective services involvement and their belief they would be treated unfairly because of their race.
We are looking for participants who are currently pregnant or have recently been pregnant to join our research study on medical insurance and racial health equity.
https://pitt.co1.qualtrics.com/jfe/form/SV_87l9XdV0xkCSrm6?Q_CHL=qr
If you would like more info, please call 412-624-3029 or email: STREAMR@pitt.edu
In this review article, Dr. Janet Catov and her team describe CARDIA (Coronary Artery Risk Development in Young Adults) studies for each reproductive milestone (contraception, PCOS, pregnancy, GDM, preterm delivery, hypertensive disorders of #pregnancy, preeclampsia, gestational hypertension, lactation, breast/chest feeding, menopause, reproductive aging, infertility, and hot flashes).
Read more here : https://pubmed.ncbi.nlm.nih.gov/36847077/
Dr. Liz Mosley and her team found that Georgia’s law limiting abortion to early pregnancy would eliminate access to abortion for nearly 90% of patients in Georgia and disproportionately harm patients who are Black, younger, and in lower socioeconomic status groups.
Read more here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802001
Dr. Judy Chang and her team examined the prevalence or correlations of cannabidiol (CBD) use among pregnant people under the age of 22.
Read the study here: https://pubmed.ncbi.nlm.nih.gov/36717004/
Alice Gao, Dr. Liz Krans, and Dr. Marian Jarlenski found that later diagnosis of opioid use disorder (OUD) in pregnancy among non-White/Hispanic women partially explains the disparities in medication for opioid use disorder (MOUD) receipt in this population. Universal substance use screening earlier in pregnancy, combined with connecting patients to evidence-based and culturally competent care, is an approach that could close the observed racial-ethnic disparity in MOUD receipt.
![Descriptive survey data from the Pregnancy-Unique Quantification of Emesis (PUQE) tool for the total PUQE score (A) and components of PUQE score (hours of nausea [B], episodes of vomiting [C], and episodes of dry heaves [D]) among those with and without detectable urine 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH). The PUQE score evaluates symptoms over the previous 12 hours. E. Logistic regression model results for the association between THC-COOH and the primary outcome.](/sites/default/files/styles/medium/public/2023-01/Screenshot%202023-01-06%20at%2011.39.49%20AM.png?itok=sVkAJv2p)
Dr. Jarlenski and her team evaluated whether cannabis use was associated with nausea and vomiting in early pregnancy, and found that higher THC levels were associated with increased odds of moderate-to-severe nausea (20.7% THC detected vs 15.5% in THC not detected).
